Financhill
Buy
53

IBM Quote, Financials, Valuation and Earnings

Last price:
$222.50
Seasonality move :
4.21%
Day range:
$221.68 - $227.68
52-week range:
$157.89 - $239.35
Dividend yield:
2.99%
P/E ratio:
32.51x
P/S ratio:
3.32x
P/B ratio:
8.45x
Volume:
12.2M
Avg. volume:
4.3M
1-year change:
39.56%
Market cap:
$206.5B
Revenue:
$61.9B
EPS (TTM):
$6.87
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $57.7B $55.2B $57.4B $60.5B $61.9B
Revenue Growth (YoY) -27.49% -4.39% 3.94% 5.54% 2.2%
 
Cost of Revenues $26.2B $24.3B $25.9B $27.8B $27.6B
Gross Profit $31.5B $30.9B $31.5B $32.7B $34.3B
Gross Profit Margin 54.64% 55.94% 54.9% 54% 55.45%
 
R&D Expenses $5.9B $6.3B $6.5B $6.6B $6.8B
Selling, General & Admin $18.7B $20.6B $18.7B $17.5B $18B
Other Inc / (Exp) $1B -$802M -$925M -$5.9B $253M
Operating Expenses $24B $26.2B $24.6B $24.5B $24.9B
Operating Income $7.5B $4.7B $6.9B $8.2B $9.4B
 
Net Interest Expenses $1.3B $1.3B $1.1B $1.1B $937M
EBT. Incl. Unusual Items $7.2B $2.6B $4.8B $1.2B $8.7B
Earnings of Discontinued Ops. $2.3B $1.7B $1B -$143M -$12M
Income Tax Expense $60M -$1.4B $124M -$626M $1.2B
Net Income to Company $9.4B $5.6B $5.7B $1.6B $7.5B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $9.4B $5.6B $5.7B $1.6B $7.5B
 
Basic EPS (Cont. Ops) $10.63 $6.28 $6.41 $1.82 $8.23
Diluted EPS (Cont. Ops) $10.56 $6.23 $6.35 $1.80 $8.14
Weighted Average Basic Share $887.2M $890.3M $896M $902.7M $911.2M
Weighted Average Diluted Share $892.8M $896.6M $904.6M $912.3M $922.1M
 
EBITDA $14.6B $10.6B $12.4B $7.2B $14.7B
EBIT $8.6B $3.9B $6B $2.4B $10.3B
 
Revenue (Reported) $57.7B $55.2B $57.4B $60.5B $61.9B
Operating Income (Reported) $7.5B $4.7B $6.9B $8.2B $9.4B
Operating Income (Adjusted) $8.6B $3.9B $6B $2.4B $10.3B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $17.6B $13.3B $14.1B $14.8B $15B
Revenue Growth (YoY) -2.59% -24.54% 6.45% 4.58% 1.46%
 
Cost of Revenues $9.1B $6.1B $6.7B $6.7B $6.5B
Gross Profit $8.4B $7.1B $7.4B $8B $8.4B
Gross Profit Margin 48% 53.63% 52.67% 54.39% 56.26%
 
R&D Expenses $1.5B $1.6B $1.6B $1.7B $1.9B
Selling, General & Admin $4.4B $4B $4.1B $4.2B $4.6B
Other Inc / (Exp) -$257M -$249M -$5.8B $58M -$2.4B
Operating Expenses $6B $5.8B $5.9B $6B $6.5B
Operating Income $2.4B $1.3B $1.5B $2.1B $1.9B
 
Net Interest Expenses $308M $276M $242M $256M $259M
EBT. Incl. Unusual Items $1.8B $813M -$4.5B $1.9B -$802M
Earnings of Discontinued Ops. -$1M $93M $18M -$10M -$13M
Income Tax Expense $128M -$224M -$1.3B $159M -$485M
Net Income to Company $1.7B $1.1B -$3.2B $1.7B -$330M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $1.7B $1.1B -$3.2B $1.7B -$330M
 
Basic EPS (Cont. Ops) $1.90 $1.26 -$3.54 $1.87 -$0.36
Diluted EPS (Cont. Ops) $1.89 $1.25 -$3.54 $1.84 -$0.36
Weighted Average Basic Share $891.4M $897.1M $904.1M $912.8M $923.6M
Weighted Average Diluted Share $897.3M $906M $904.1M $923.7M $923.6M
 
EBITDA $3.8B $2.8B -$3B $3.4B $895M
EBIT $2.2B $1.1B -$4.2B $2.3B -$373M
 
Revenue (Reported) $17.6B $13.3B $14.1B $14.8B $15B
Operating Income (Reported) $2.4B $1.3B $1.5B $2.1B $1.9B
Operating Income (Adjusted) $2.2B $1.1B -$4.2B $2.3B -$373M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $55.6B $42.6B $60.5B $61.2B $62.6B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $24.4B $14.8B $28B $27.5B $27.2B
Gross Profit $31.2B $27.8B $32.6B $33.7B $35.4B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $6.2B $6.4B $6.6B $6.6B $7.3B
Selling, General & Admin $19B $18.8B $18.7B $18B $18.6B
Other Inc / (Exp) -$229M -$1B -$6B $265M -$2.2B
Operating Expenses $25.1B $24.4B $24.7B $24.8B $25.9B
Operating Income $6.1B $3.4B $7.8B $8.9B $9.4B
 
Net Interest Expenses $1.5B $1.2B $1.1B $924M $953M
EBT. Incl. Unusual Items $4.4B $1.2B $713M $8.2B $6.3B
Earnings of Discontinued Ops. $2.3B $2.8B -$114M -$174M $24M
Income Tax Expense -$1.2B -$755M -$663M $1.1B -$124M
Net Income to Company $7.9B $4.8B $1.3B $6.9B $6.4B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $7.9B $4.8B $1.3B $6.9B $6.4B
 
Basic EPS (Cont. Ops) $8.89 $5.33 $1.42 $7.62 $6.97
Diluted EPS (Cont. Ops) $8.83 $5.29 $1.37 $7.53 $6.87
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $12.4B $9.1B $7B $14.1B $12.6B
EBIT $5.7B $2.4B $1.9B $9.8B $7.9B
 
Revenue (Reported) $55.6B $42.6B $60.5B $61.2B $62.6B
Operating Income (Reported) $6.1B $3.4B $7.8B $8.9B $9.4B
Operating Income (Adjusted) $5.7B $2.4B $1.9B $9.8B $7.9B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $53.3B $40.7B $43.8B $44.5B $45.2B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $28.2B $18.7B $20.8B $20.4B $20.1B
Gross Profit $25.1B $22B $23.1B $24B $25.1B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $4.7B $4.9B $5B $5B $5.5B
Selling, General & Admin $14.9B $13.1B $13B $13.5B $14B
Other Inc / (Exp) -$691M -$911M -$6B $198M -$2.3B
Operating Expenses $20.1B $18.3B $18.4B $18.6B $19.6B
Operating Income $4.9B $3.7B $4.7B $5.4B $5.5B
 
Net Interest Expenses $883M $812M $805M $675M $691M
EBT. Incl. Unusual Items $3.3B $2B -$2.2B $4.9B $2.5B
Earnings of Discontinued Ops. -$3M $1.2B $16M -$15M $21M
Income Tax Expense -$889M -$283M -$1.1B $702M -$598M
Net Income to Company $4.2B $3.4B -$1.1B $4.2B $3.1B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $4.2B $3.4B -$1.1B $4.2B $3.1B
 
Basic EPS (Cont. Ops) $4.75 $3.81 -$1.18 $4.63 $3.38
Diluted EPS (Cont. Ops) $4.72 $3.78 -$1.20 $4.57 $3.32
Weighted Average Basic Share $2.7B $2.7B $2.7B $2.7B $2.8B
Weighted Average Diluted Share $2.7B $2.7B $2.7B $2.8B $2.8B
 
EBITDA $9.3B $7.9B $2.4B $9.4B $7.3B
EBIT $4.3B $2.8B -$1.3B $6.1B $3.8B
 
Revenue (Reported) $53.3B $40.7B $43.8B $44.5B $45.2B
Operating Income (Reported) $4.9B $3.7B $4.7B $5.4B $5.5B
Operating Income (Adjusted) $4.3B $2.8B -$1.3B $6.1B $3.8B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $8.2B $13.2B $6.7B $7.9B $13.1B
Short Term Investments $696M $600M $600M $852M $373M
Accounts Receivable, Net $7.9B $5.8B $6.8B $6.5B $7.2B
Inventory $1.6B $1.8B $1.6B $1.6B $1.2B
Prepaid Expenses -- -- -- -- --
Other Current Assets $2.1B $2.1B $3.5B $2.6B $2.6B
Total Current Assets $38.4B $39.2B $29.5B $29.1B $32.9B
 
Property Plant And Equipment $15B $9.8B $8.9B $8.2B $8.7B
Long-Term Investments $222M $216M -- -- --
Goodwill $58.2B $53.8B $55.6B $55.9B $60.2B
Other Intangibles $15.2B $13.7B $12.5B $11.2B $11B
Other Long-Term Assets $321M $13.3B $1.8B $1.6B $1.6B
Total Assets $152.2B $156B $132B $127.2B $135.2B
 
Accounts Payable $4.9B $4B $4B $4.1B $4.1B
Accrued Expenses $4.4B $5.6B $3.9B $4.1B $3.5B
Current Portion Of Long-Term Debt $8.5B $7.1B $6.8B $4.8B $6.4B
Current Portion Of Capital Lease Obligations $1.4B $1B $974M $874M $820M
Other Current Liabilities -- $3.8B $1M -- $1M
Total Current Liabilities $37.7B $39.9B $33.6B $31.5B $34.1B
 
Long-Term Debt $54.1B $54.2B $44.9B $46.2B $50.1B
Capital Leases -- -- -- -- --
Total Liabilities $131.2B $135.2B $113B $105.2B $112.6B
 
Common Stock $55.9B $56.6B $57.3B $58.3B $59.6B
Other Common Equity Adj -$28.6B -$29.3B -$23.2B -$16.7B -$18.8B
Common Equity $20.8B $20.6B $18.9B $21.9B $22.5B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $144M $129M $95M $77M $80M
Total Equity $21B $20.7B $19B $22B $22.6B
 
Total Liabilities and Equity $152.2B $156B $132B $127.2B $135.2B
Cash and Short Terms $8.9B $13.8B $7.3B $8.7B $13.4B
Total Debt $62.9B $61.3B $51.7B $50.9B $56.5B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $14.4B $7.5B $7.8B $7.3B $13.2B
Short Term Investments $1.2B $600M $1.8B $3.7B $505M
Accounts Receivable, Net $6.1B $6.6B $5.5B $5.3B $5.4B
Inventory $1.9B $1.9B $1.8B $1.4B $1.4B
Prepaid Expenses -- -- -- -- --
Other Current Assets $2.2B $3B $3.5B $2.6B $2.4B
Total Current Assets $39.8B $30B $29B $27.7B $30.5B
 
Property Plant And Equipment $14.7B $13.4B $7.9B $8.5B $9B
Long-Term Investments -- -- -- -- --
Goodwill $58.4B $61.4B $54.2B $59.6B $61.1B
Other Intangibles $14B $13B $11B $11.3B $11.1B
Other Long-Term Assets $1.9B $2B $1.6B $1.6B $2B
Total Assets $154.1B $144.2B $125.9B $129.3B $134.3B
 
Accounts Payable $4B $4.2B $3.8B $3.3B $3.3B
Accrued Expenses $4.7B $4.5B $3.7B $3.3B $3.5B
Current Portion Of Long-Term Debt $10.3B $6.7B $5.9B $6.4B $3.6B
Current Portion Of Capital Lease Obligations $1.3B $1.3B $844M $807M $790M
Other Current Liabilities -$2M $1M $2M $2M --
Total Current Liabilities $38B $35.8B $30.5B $30.6B $28.9B
 
Long-Term Debt $55.1B $46.9B $44.9B $48.8B $53B
Capital Leases -- -- -- -- --
Total Liabilities $132.8B $121.9B $105.7B $106.2B $109.8B
 
Common Stock $56.4B $57.2B $58.1B $59.3B $61B
Other Common Equity Adj -$28.6B -$27.3B -$17.1B -$16.1B -$16.4B
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $126M $129M $71M $75M $82M
Total Equity $21.3B $22.4B $20.1B $23.2B $24.5B
 
Total Liabilities and Equity $154.1B $144.2B $125.9B $129.3B $134.3B
Cash and Short Terms $15.6B $8.1B $9.6B $11B $13.7B
Total Debt $65.4B $54.5B $50.9B $55.2B $56.6B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $9.4B $5.6B $5.7B $1.6B $7.5B
Depreciation & Amoritzation $6.1B $6.7B $6.4B $4.8B $4.4B
Stock-Based Compensation $679M $937M $982M $987M $1.1B
Change in Accounts Receivable $502M $5.3B $1.4B -$539M $725M
Change in Inventories $67M -$209M $138M $71M $390M
Cash From Operations $14.8B $18.2B $12.8B $10.4B $13.9B
 
Capital Expenditures $2.9B $3.2B $2.8B $2B $1.8B
Cash Acquisitions -$31.6B $167M -$3.2B -$1.1B -$5.1B
Cash From Investing -$26.9B -$3B -$6B -$4.2B -$7.1B
 
Dividends Paid (Ex Special Dividend) -$5.7B -$5.8B -$5.9B -$5.9B -$6B
Special Dividend Paid
Long-Term Debt Issued $31.8B $10.5B $522M $7.8B $9.6B
Long-Term Debt Repaid -$12.9B -$13.4B -$8.6B -$6.8B -$5.1B
Repurchase of Common Stock -$1.6B -$302M -$319M -$407M -$402M
Other Financing Activities $98M $92M $949M $176M $176M
Cash From Financing $9B -$9.7B -$13.4B -$5B -$1.8B
 
Beginning Cash (CF) $11.6B $8.3B $13.7B $7B $8B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$3.1B $5.4B -$6.5B $1.3B $5.1B
Ending Cash (CF) $8.3B $13.7B $7B $8B $13.1B
 
Levered Free Cash Flow $11.9B $15B $10B $8.5B $12.1B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $1.7B $1.1B -$3.2B $1.7B -$330M
Depreciation & Amoritzation $1.7B $1.7B $1.2B $1.1B $1.3B
Stock-Based Compensation $222M $262M $251M $287M $330M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $4.3B $2.7B $1.9B $3.1B $2.9B
 
Capital Expenditures $893M $734M $455M $393M $424M
Cash Acquisitions -$265M -$101M -$59M -$4.6B -$2.5B
Cash From Investing -$332M -$629M -$1.7B -$2B -$1.6B
 
Dividends Paid (Ex Special Dividend) -$1.5B -$1.5B -$1.5B -$1.5B -$1.5B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $147M $151M $3.4B $154M --
Long-Term Debt Repaid -$379M -$1.3B -$1.5B -$1.7B -$1.3B
Repurchase of Common Stock -$14M -$18M -$14M -$98M -$189M
Other Financing Activities $28M $29M $80M $31M $225M
Cash From Financing -$1.7B -$1.7B $713M -$3.1B -$2.8B
 
Beginning Cash (CF) $12.2B $7.6B $7.3B $9.4B $14.5B
Foreign Exchange Rate Adjustment $101M -$94M -$196M -$119M $207M
Additions / Reductions $2.3B $335M $917M -$2B -$1.5B
Ending Cash (CF) $14.6B $7.8B $8B $7.3B $13.2B
 
Levered Free Cash Flow $3.4B $2B $1.4B $2.7B $2.5B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $7.9B $4.8B $1.3B $6.9B $6.4B
Depreciation & Amoritzation $6.6B $6.7B $5B $4.4B $4.7B
Stock-Based Compensation $869M $998M $1B $1.1B $1.3B
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $15.8B $16.1B $9B $13.4B $13.6B
 
Capital Expenditures $3.1B $3B $2B $1.9B $1.7B
Cash Acquisitions $622M -$3.3B $64M -$6.3B -$2.2B
Cash From Investing -$2.3B -$5.9B -$3.6B -$11.2B -$722M
 
Dividends Paid (Ex Special Dividend) -$5.8B -$5.8B -$5.9B -$6B -$6.1B
Special Dividend Paid
Long-Term Debt Issued $10.7B $561M $7.9B $9.6B $5.7B
Long-Term Debt Repaid -$12.9B -$11.9B -$6.7B -$6.3B -$6.6B
Repurchase of Common Stock -$311M -$329M -$396M -$416M -$603M
Other Financing Activities $102M $92M $982M $158M $603M
Cash From Financing -$9.1B -$17B -$4.8B -$3B -$7B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $4.3B -$6.7B $658M -$799M $5.8B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $12.7B $13.1B $7B $11.5B $11.9B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $4.2B $3.4B -$1.1B $4.2B $3.1B
Depreciation & Amoritzation $5B $5B $3.7B $3.2B $3.6B
Stock-Based Compensation $658M $719M $739M $843M $966M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $12.3B $10.3B $6.5B $9.5B $9.1B
 
Capital Expenditures $2.4B $2.2B $1.4B $1.4B $1.2B
Cash Acquisitions $473M -$3B $251M -$4.9B -$2B
Cash From Investing -$2.5B -$5.3B -$2.9B -$9.9B -$3.6B
 
Dividends Paid (Ex Special Dividend) -$4.3B -$4.4B -$4.5B -$4.5B -$4.6B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $10.3B $394M $7.8B $9.6B $5.7B
Long-Term Debt Repaid -$8.8B -$7.3B -$5.4B -$5B -$6.5B
Repurchase of Common Stock -$225M -$252M -$329M -$338M -$539M
Other Financing Activities $72M $72M $105M $87M $514M
Cash From Financing -$3.4B -$10.7B -$2.1B -$154M -$5.4B
 
Beginning Cash (CF) $31.9B $31.9B $24.4B $26.9B $42.3B
Foreign Exchange Rate Adjustment -$200M -$159M -$463M -$120M -$29M
Additions / Reductions $6.4B -$5.7B $1.5B -$593M $154M
Ending Cash (CF) $38.1B $26B $25.4B $26.2B $42.5B
 
Levered Free Cash Flow $9.9B $8.1B $5.1B $8.1B $7.9B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is down 0.09% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 7.53% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 6.1% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock